Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.7 |
mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.07 | 0.7 |
mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.062 | 0.7 |